References
- WiersmaTSmuldersYMStehouwerCDKoningsKTLanphenJSamenvatting van de multidisciplinaire richtlijn Cardiovasculair risicomanagement (herziening 2011) [Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)]Ned Tijdschr Geneeskd201215636A510422951134
- New Zealand Guidelines GroupNew Zealand Cardiovascular Guidelines Handbook2nd edWellingtonNew Zealand Guidelines Group200992
- National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee)Guide to Management of Hypertension 2008 Updated December 2010CanberraHeart Foundation201030 Available from: http://heartfoundation.org.au/images/uploads/publications/HypertensionGuidelines2008to2010Update.pdfAccessed April 15, 2017
- Newcastle guideline Development and Research Unit; updated by the National Clinical Guideline Centre (formerly the National Collaborating Centre for Chronic Conditions) and the British Hypertension SocietyHypertension Clinical Management of Primary Hypertension in AdultsLondonNational Institute for Health and Clinical Excellence201134 Available from: http://www.ehs-egypt.net/pdf/WhatsnewNICE2011.pdfAccessed April 15, 2017
- GohlkeHAlbusCBönnerGRisikoadjustierte Prävention von Herz-und Kreislauferkrankungen [Risk-adjustedprevention of heart-and circulatory diseases]DüsseldorfVorstand der Deutschen Gesellschaft für Kardiologie–Herz-und Kreislaufforschung eV200739 Available from: http://leitlinien.dgk.org/files/2007_Pocket-Leitlinien_Risikoad-justierte_Praevention.pdfAccessed April 15, 2017
- PerkJDe BackerGGohlkeHEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Eur Heart J201233131635170122555213
- van DuijnHJBeloJNBlomJWVelbergIDAssendelftWJRevised guidelines for cardiovascular risk management – time to stop medication? A practice-based intervention studyBr J Gen Pract201161587347352
- LuymesCHde RuijterWPoortvlietRKChange in calculated cardiovascular risk due to guideline revision: a cross-sectional study in the NetherlandsEur J Gen Pract201521421722326230039
- LuymesCHvan der KleijRMPoortvlietRKde RuijterWReisRNumansMEDeprescribing potentially inappropriate preventive cardiovascular medication: barriers and enablers for patients and general practitionersAnn Pharmacother201650644645426939589
- MorecroftCCantrillJTullyMPIndividual patient’s preferences for hypertension management: a Q-methodological approachPatient Educ Couns200661335436215896942
- BensonJBrittenNPatients’ decisions about whether or not to take antihypertensive drugs: qualitative studyBMJ2002325736987312386041
- BezrehTLawsMBTaubinTRifkinDEWilsonIBChallenges to physician–patient communication about medication use: a window into the skeptical patient’s worldPatient Prefer Adherence201261111822272065
- ReeveEToJHendrixIShakibSRobertsMSWieseMDPatient barriers to and enablers of deprescribing: a systematic reviewDrugs Aging2013301079380723912674
- DohnhammarUReeveJWalleyTPatients’ expectations of medicines – a review and qualitative synthesisHealth Expect201619217919325639697
- WattsSStennerPDoing Q methodology: theory, method and interpretationQualitative Res Psychol2005216791
- ZabalaAqmethod: a package to explore human perspectives using Q methodologyR J201562163173
- MarshallIJWolfeCDMcKevittCLay perspectives on hypertension and drug adherence: systematic review of qualitative researchBMJ2012345e395322777025
- PoundPBrittenNMorganMResisting medicines: a synthesis of qualitative studies of medicine takingSoc Sci Med200561113315515847968